⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 13, 2024

Supplementary Figure 7 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 7. BRAF signaling pathway inhibition in a subcutaneous BRAFV600E PMP-PDX model.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Martínez‐Quintanilla et al. (2024) studied this question.

synapsesocial.com/papers/68e58a5ab6db64358752635e https://doi.org/10.1158/1078-0432.27013757

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 7 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei2024
2Supplementary Figure 9 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei2024
3Supplementary Figure 9 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei2024
4Supplementary Figure 8 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei2024
5Supplementary Figure 8 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei2024